Main Text
PCGF2 [MIM 600346 ] encodes the polycomb group ring finger 2 protein (PCGF2, aka MEL18).
The PCGF2 protein contains an N-terminal RING finger motif and is similar in structure to other polycomb-group (PcG) proteins.
1 PCGF2 has been implicated in cell proliferation, 2 X inactivation, 3 regulation of homeobox genes during embryogenesis, 4 mesoderm differentiation, 5 hemopoiesis, 6 tumor suppression 7, 8 and angiogenesis. 9, 10 PCGF2 is widely expressed in human tissues. 1, 11 It binds to a specific DNA sequence (5'-GACTNGACT-3') in the promoter regions of target genes. 7 PCGF2
is a component of a multiprotein complex called the polycomb repressive complex 1 (PRC1), an essential regulator, via histone modification and chromatin remodeling, of transcription in embryonic and adult stem cells. 12, 13 The core of mammalian PRC1 typically contains an E3
ubiquitin ligase (RING1A/B [MIM 602045/608985]), 3, 14 that ubiquitinates histone H2A at lysine 119, along with a PCGF protein (PCGF1-6) 15 which regulates the enzyme activity of the complex.
PRC1 complexes often include other PcG components (e.g. polyhomeotic homologue or chromobox homologue proteins), which guide recruitment of PRC1 to the chromatin. 12 The variable composition of PRC1 allows the complex to modulate function depending on cell type and developmental stage. A range of other proteins involved in Histone H2A ubiquitination have been linked to neurodevelopmental disorders. 16 These include proteins involved in both adding [17] [18] [19] and removing [20] [21] [22] Figure S2 ).
The intellectual disability/developmental delay in the subjects ranged from mild to severe. Most individuals had difficulties with verbal communication. Three had absent speech at the time of assessment (at 21 years, 9 years and 30 months of age). Muscular hypotonia (9/13) and conductive hearing impairment (7/13) were common. Only two subjects had a history of confirmed seizures. Intrauterine growth restriction was noted during three pregnancies (borderline in one more). All the subjects had a birth weight below the mean for gestational age. Weight during childhood remained low, compounded by feeding difficulties (9/13) and/or gastroesophageal reflux (6/13). The feeding problems and reflux improved slowly with age. Constipation was also common (8/12), sometimes severe. Height during childhood was generally low for age although three subjects had heights just above the mean. The effects on head size were variable. Individual 1, the oldest and most intellectually impaired individual in the group, had a relatively large head size from early childhood, originally attributed to arrested hydrocephalus (occipitofrontal circumference [OFC] +1.8 SD, height and weight 1-2 SD below the mean). Relative macrocephaly was noted in two other individuals. In contrast, four individuals had small heads (OFC <-2 SD). Eleven subjects had cardiac abnormalities. Findings included patent ductus arteriosus (PDA) (5/13), atrial septal defect The identified mutations all affected the Pro65 residue of PCGF2. This residue is located just after the N-terminal RING finger motif and is highly conserved across species and other human PCGF proteins ( Figure 3A,B) . No variants have been reported at this position in the gnomAD database in PCGF2, or at the equivalent proline in other human PCGF proteins. Both mutations were predicted to be deleterious by a majority of in silico prediction programs (Table S1 ). To explore the effects of Pro65 mutations, we modelled the structure of the N-terminal of PCGF2 (amino acids 5-101) based on solved crystal structures for its homolog, BMI1 (PCGF4) [MIM 164831]. Two templates were used, PDB 2h0d (BMI1 bound to RING1B) 25 and 4r8p (BMI1-PRC1 complex bound to nucleosome), 26 with essentially identical results. Pro65 is situated at the junction between an extended loop region and a short α-helix ( Figure 3C ). The presence of proline at this position is likely to maintain the transition from loop to helix. Furthermore, given the rotational constraint imposed by proline's ring structure, this residue is likely to provide the loop region with a degree of structural rigidity. 27 Thermodynamic analysis of the 2h0d-based PCGF2 model using FoldX showed the Pro65 variants resulted in changes to thermodynamic stability ( G) of +8.6 kcal/mol and +3.9 kcal/mol for p.Pro65Leu and p.Pro65Ser respectively; G values values >3 kcal/mol are generally regarded as destabilizing. 28 Intriguingly, the loop region next to Pro65 contains two basic residues, Lys62 and Arg64, which form a basic patch on BMI1 and the predicted surface of PCGF2
( Figure 3D ,E). PRC1 complexes containing PCGF2 (or BMI1) have low intrinsic ubiquitin ligase activity compared to complexes containing other PCGF proteins. 29 This is compensated for by an increased affinity for the nucleosomal substrate, leading to efficient histone ubiquitylation. The increased affinity is dependent on residues Lys62 and Arg64, which interact with an acidic patch on the surface of histones 3 and 4 ( Figure 3F ). This raises the possibility that the interaction between PCGF2 and histones is disrupted by the structural perturbations caused by Pro65 substitutions.
The extreme clustering of disease-causing de novo missense mutations in PCGF2 is highly statistically significant and similar to other genes with non-haploinsufficient disease mechanisms. 30 No truncating mutations were observed in our cohort. In contrast, several truncating PCGF2 variants are listed by the gnomAD database. This argues against a simple haploinsufficiency mechanism. The probability of PCGF2 being loss-of-function intolerant (pLI) 31 in the Exome Aggregation Consortium (ExAC) is only 0.55. Furthermore, no interstitial deletions involving PCGF2 are listed on the DECIPHER database. Loss of PSc (the homolog of PCGF) in Drosophila melanogaster leads to mis-expression of homeotic genes and defects in segmental determination. 32 Similarly, homzoygote Pcgf2-deficient mice exhibit disturbed Hox gene expression with posterior transformations of the axial skeleton and growth retardation. 4 However, heterozygous Pcgf2-deficient mice were normal, and no abnormalities of craniofacial structure or neurology were identified in the homozygotes. Our in silico structural modelling suggests substitution of Pro65 disrupts the interaction of PCGF2 with histones. This provides a plausible molecular mechanism for a dominant negative effect. Mutant PCGF2 may retain the ability to sequester other PcG components into PRC1 complexes but, due to disruption of the loop structure around Lys62 and Arg64, mutant PRC1 complexes may lack the ability to interact efficiently with histones. Detailed functional experiments will be required to distinguish between these and other possible pathogenesic mechanisms at a molecular level.
PCGF2 regulates differentiation of the cardiac mesoderm, which may contribute to the cardiac anomalies seen. 5 Aortic dilation was found in five of the subjects (severe in individual 1, the young adult). We would therefore recommend that all PCGF2 patients have periodic echocardiographic downstream effector of the PI3K-AKT pathway in developing neuroblasts. 33 Gain-of-function mutations in CCND2 and other components of the PI3K-AKT pathway have been found to cause polymicrogyria, macrocephaly and ventricular dilation. 34, 35 Knockdown of PCGF2 has been shown to increase proliferative activity in cells over-expressing CCND2. 33 If Pro65 mutations reduce PCGF2's ability to inhibit CCND2, the increased CCND2 activity may predispose to polymicrogyria. The CCND2 binding site has been mapped to the C-terminal proline/serine-rich domain of PCGF2. 33 Therefore, mutation of the N-terminal Pro65 residue is unlikely to directly block binding of CCND2. The presence of vascular abnormalities (and the twin placental circulation of individuals 3 and 4) may be additional risk factors for the polymicrogyria. 36 The variable head size observed in subjects may reflect the conflicting effects of abnormal vasculature (impairing brain growth and causing the deep cerebral white matter changes) and altered signaling through the PI3K-AKT-CCND2 pathway (promoting brain growth and ventricular dilation). PCGF2
has tumor suppression activity and has been implicated in a range of tumor types. 7, [37] [38] [39] To date, none of the subjects with PCGF2 Pro65 mutations has been diagnosed with malignancy.
In summary, we have reported 13 individuals with missense substitutions of the Pro65 residue of PCGF2. These individuals have a recognisable phenotype of developmental delay, intellectual disability, impaired growth, and characteristic facial features that include frontal bossing, sparse hair, malar hypoplasia, small palpebral fissures and oral stoma, and dysplastic 'satyr' ears. Other common findings in the subjects included feeding problems, constipation, and a range of brain, cardiac, vascular and skeletal malformations. Further work is required to define the precise pathogenic mechanism of PCGF2 mutations; however, our modelling and the available genetic data suggests that PCGF2 Pro65 mutations have dominant-negative effects on PRC1 function, altering multiple signaling pathways and therefore resulting in the complex human phenotype. 
